Igen, ZymoGenetics deal

ZymoGenetics, a wholly-owned subsidiary of Novo Nordisk A/S (Bagsvaerd, Denmark), will purchase IGEN's Origen high throughput drug discovery system, which is based on electrochemiluminescence. ...